Table 2 Neoepitope analysis of clinical study patients.

Patient identification number, total number of nonsynonymous somatic mutations, HLA class I haplotypes, and number of predicted neoepitopes.

PatientNonsynonymous
mutations
HLA-AHLA-BHLA-CPredicted
neoepitopes*
CTE-000811724:0269:0115:0151:0103:0316:02101
CTE-00109002:0131:0115:0135:0203:0304:01133
CTE-001110811:0124:0215:1845:0106:0207:0484
CTE-00135602:0633:0335:0158:0103:0203:0379
CTE-001510511:0102:1407:0227:0502:0207:02119
CTE-00196402:1102:1140:0640:0615:0215:0250

*Based on netMHC.